News & Analysis as of

Proposed Legislation Regulatory Requirements Trump Administration

Goodwin

A Look Ahead in Life Sciences: What We Are Tracking in the Third Quarter of 2025 and Beyond

Goodwin on

As the life sciences, medtech, and diagnostic industries continue to grow increasingly complex, so does the legal, regulatory, and compliance landscape. To help companies and investors navigate the many evolving and emerging...more

Goodwin

Federal AI Moratorium Dies on the Vine as Senate Passes the “One Big Beautiful Bill”

Goodwin on

On July 1, 2025, in a near-unanimous, 99-1 vote, the U.S. Senate stripped the AI moratorium provisions originally included in the “One Big Beautiful Bill Act." The AI moratorium, which we previously covered here, would have...more

Ballard Spahr LLP

Senate Parliamentarian says elimination of CFPB funding cannot be included in budget bill but delay of Section 1071 rule passes...

Ballard Spahr LLP on

The Senate parliamentarian has ruled that a key Senate Banking, Housing and Urban Affairs (Banking Committee) provision that would eliminate all funding for the CFPB cannot be included in the massive budget reconciliation...more

Troutman Pepper Locke

FUNDamentals — June 2025

Troutman Pepper Locke on

FUNDamentals is a periodic digest of news and information specifically for private funds and their managers. In this issue, we highlight some fundraising trends, new marketing rule FAQs, fund liquidity trends (limited...more

Troutman Pepper Locke

2025 Digital Asset Developments - Navigating Change: First 100 Days Under the Trump Administration

Troutman Pepper Locke on

We are pleased to share with you our latest publication, “Navigating Change: First 100 Days under the Trump Administration,” authored by our Digital Assets + Blockchain team. This retrospective examines the pivotal...more

Hogan Lovells

AI Summit panelists forecast FDA regulatory climate in second Trump administration

Hogan Lovells on

Evolving regulatory paradigms governing AI use in health care at the U.S. Food and Drug Administration (FDA) have set the pace for AI regulatory frameworks worldwide. Jodi Scott, partner in the Hogan Lovells medical device &...more

Troutman Pepper Locke

PFAS Regulatory Landscape Update — The Message? Stay Tuned.

Troutman Pepper Locke on

The Environmental Protection Agency (EPA) has announced several actions in recent weeks that shed light on the Trump administration’s approach to PFAS regulation....more

King & Spalding

AI Quarterly Update: Recent AI Legislation Efforts Signal Potential Challenges for State-Led Regulatory Approach

King & Spalding on

In Q1 of 2025, there have been significant regulatory and policy developments at the state, federal, and international level regarding artificial intelligence (“AI”). In Europe, the phased implementation of the European...more

Akin Gump Strauss Hauer & Feld LLP

Rescission of Useless Water Pressure Standards (Trump EO Tracker)

Directs the Secretary of Energy to rescind or amend specific appliance efficiency regulations, suspend enforcement of those provisions and related statutory standards. It also instructs the Secretary and the Director of...more

Husch Blackwell LLP

States Could Fill Potential Enforcement Gaps on Climate Disclosures

Husch Blackwell LLP on

On March 6, 2024, the Securities and Exchange Commission (SEC) issued new rules aimed at standardizing climate-related disclosures by public companies. Commonly known as the SEC climate disclosure rules, they require...more

King & Spalding

REPAIR Act Redux and a New Presidential Memorandum—No End in Sight for NEPA Uncertainty

King & Spalding on

The National Environmental Policy Act has drawn congressional and presidential frustration for long over a decade and the regulations of the body it created—the Council on Environmental Quality—have often been caught in the...more

Foley & Lardner LLP

DEA Buprenorphine Rule Delayed to December 31, 2025

Foley & Lardner LLP on

The U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have postponed the effective date of the final rule regarding telemedicine prescribing of buprenorphine (the final...more

Moore & Van Allen PLLC

Will Congress Clarify Regulation of Marijuana-Related Business?

Moore & Van Allen PLLC on

President Trump piqued the interest of participants in and observers of the marijuana industry when he stated in early June that he would “probably” support recently proposed bipartisan legislation aimed at removing the...more

13 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide